ASLN

ASLAN Pharmaceuticals Limited (ASLN) | Rumor.io

ASLAN Pharmaceuticals

ASLN

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about ASLN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Jul 18

ASLN has been oversold, with an RSI of 21.74, and is considered undervalued by analysts, with a price target of $9.50.
The company's stock has fallen 69% in the past five days, and has a 52-week low of $0.48, but some analysts believe it could make a run for $1.00.
ASLN has been liquidated, with its Singapore-incorporated subsidiary filing for voluntary liquidation due to a thorough review of its financial situation and strategic options.

Generated by AI

Sentiment

Of the messages about ASLN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	60% -35.44
Bearish	—	—	—	40% +35.44

Bullish· Mar 13

$ASLN has a strong potential for real gains within the next year, with a price target of $10.
The company's low market cap of around $11 million, combined with its cash and Phase 3 ready asset, make it a promising rebound play.
$ASLN is trending over its EMAs and may be due for a further run, but also a drop, with a next target of $2 if it breaks $1.

Bearish· Mar 12

$ASLN's recent price action has been heavily influenced by short selling, with one analyst going short the stock in anticipation of its decline.
The company's recent $5 million fundraising effort has been seen as insufficient to address its cash burn, with some speculating that it may be a bridge to a larger event.
ASLN's price has been subject to significant volatility, with some traders predicting a potential retest of a support level at $2, while others believe the stock may continue to decline to around $0.75.

Generated by AI

Topics

Of the messages about ASLN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	87.5%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	12.5%

Analysts· May 30

BTIG initiated coverage on ASLAN Pharmaceuticals Limited with a Buy rating and a $16 price target.
H.C. Wainwright and Piper Jaffray Companies initiated coverage on ASLAN Pharmaceuticals Limited with Buy and Overweight ratings, respectively, with price targets of $12 and $13.
Leerink Partners initiated coverage on ASLAN Pharmaceuticals Limited with a Market Perform rating and a $7 price target.

Announcements· Jul 3

ASLAN Pharmaceuticals Limited (ASLN) has announced a 1:8 reverse stock split, where 8 shares will become 1.
The reverse stock split will be implemented on July 3, 2024, with trading commencing on the same day.
The company will reduce its outstanding shares by 75% as a result of the reverse stock split.

Technical Analysis· Jul 9

The analyst initiated coverage of ASLN with a buy rating and a price target of $8.
The support level for ASLN is around $3.55, and a break below this area could lead to a decline to $3.30.
A break above $3.80 is needed to confirm a larger uptrend, with key indicators at $3.98 and $4.22.

Generated by AI

Community

Of the messages about ASLN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0.04%
Newcomers	—	—	—	99.96%

Regulars· Jul 3

The regulars are discussing ASLN as a trending stock on July 03, 2024, with no further information provided about the stock's performance or news.
There is no discussion about ASLN's company, ASLAN Pharmaceuticals Limited, beyond its name and ticker symbol.
The post appears to be a promotional or alert-style message, listing ASLN as a trending stock without any additional context or analysis.

Newcomers· Mar 12

Many new traders are focusing on cutting losses and taking profits, with some experiencing mixed results, such as a big red candle on $ASLN.
Some newcomers are excited about the potential of $ASLN, with one analyst predicting a price of $2 soon.
Others are following the news and updates on $ASLN, including a recent study update and a $5 million registered direct offering, which has led to significant price movement.

Generated by AI

Also Discussed

Investors talking about ASLN also mention

#	Name	Attention
1	KRTX - Karuna Therapeutics, Inc.	——
2	MYOV - Myovant Sciences Ltd.	——
3	ARAV - Aravive, Inc.	——
4	Viveve Medical Inc.VIVE	0%0
5	Nanoviricides Inc.NNVC	0%0
6	TCON - TRACON Pharmaceuticals, Inc.	——
7	Amneal Pharmaceuticals, Inc.AMRX	0%+0
8	PT - Pintec Technology Holdings Limited	——
9	Aclaris Therapeutics, Inc.ACRS	0%0
10	BIMI - BIMI International Medical Inc.	——